Sanofi CEO cautions arthritis drug a 'long shot' in COVID-19, says study results 'imminent'
The drugmaker, along with partner Regeneron, is studying whether Kevzara can ease the severe respiratory symptoms experienced by some patients.
The drugmaker, along with partner Regeneron, is studying whether Kevzara can ease the severe respiratory symptoms experienced by some patients.
